MicroRNA-328 as a regulator of cardiac hypertrophy

International Journal of Cardiology

Volumn 173, Issue 2, 2014, Pages 268-276

  Li, Cui ^a   Li, Xuelian ^a   Gao, Xu ^a   Zhang, Ruixue ^a   Zhang, Ying ^a   Liang, Haihai ^a   Xu, Chaoqian ^a   Du, Weijie ^a   Zhang, Yong ^a   Liu, Xue ^a   Ma, Ning ^a   Xu, Zhidan ^a   Wang, Leimin ^a   Chen, Xu ^a   Lu, Yanjie ^a   Ju, Jiaming ^a   Yang, Baofeng ^a   Shan, Hongli ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Calcineurin; Cardiac hypertrophy; miR 328; NFATc3; SERCA2a

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CALCINEURIN; CALCIUM; ISOPRENALINE; LOCKED NUCLEIC ACID; MICRORNA; MICRORNA 328; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE 2A; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFATC3; UNCLASSIFIED DRUG; MIRN328 MICRORNA, MOUSE; NFATC3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTISENSE THERAPY; ARTICLE; CALCIUM CELL LEVEL; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; GENE TRANSLOCATION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; MALE; MOUSE; NEWBORN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; THORACIC AORTIC BANDING; UPREGULATION; ANIMAL; C57BL MOUSE; CARDIOMEGALY; DISEASE MODEL; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; CALCINEURIN; CALCIUM; CARDIOMEGALY; DISEASE MODELS, ANIMAL; MALE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICRORNAS; MYOCYTES, CARDIAC; NFATC TRANSCRIPTION FACTORS; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SIGNAL TRANSDUCTION;

EID: 84898904933     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.02.035     Document Type: Article

References (42)

1. T. Sakoda, and T. Masuyama Cardiac hypertrophy Nihon Rinsho 63 Suppl. 3 2005 559 564
2. P. Finckenberg, and E. Mervaala Novel regulators and drug targets of cardiac hypertrophy J Hypertens 28 Suppl. 1 2010 S33 S38
3. A. Rohini, N. Agrawal, C.N. Koyani, and R. Singh Molecular targets and regulators of cardiac hypertrophy Pharmacol Res 61 2010 269 280
4. P. Balakumar, and G. Jagadeesh Multifarious molecular signaling cascades of cardiac hypertrophy: can the muddy waters be cleared? Pharmacol Res 62 2010 365 383
5. H. Akazawa Calcium signals: regulatory mechanisms of cardiac gene expression and involvement in the development of cardiac hypertrophy Clin Calcium 11 2001 719 725
6. S.A. Goonasekera, K. Hammer, and M. Auger-Messier et al. Decreased cardiac L-type Ca(2)(+) channel activity induces hypertrophy and heart failure in mice J Clin Invest 122 2012 280 290
7. 2 + signalling systems and cardiac hypertrophy Biochem Soc Trans 34 2006 228 231
8. A. Zarain-Herzberg, J. Fragoso-Medina, and R. Estrada-Aviles Calcium-regulated transcriptional pathways in the normal and pathologic heart IUBMB Life 63 2011 847 855
9. B.J. Wilkins, and J.D. Molkentin Calcium-calcineurin signaling in the regulation of cardiac hypertrophy Biochem Biophys Res Commun 322 2004 1178 1191
10. D.L. Dong, C. Chen, and R. Huo et al. Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy Hypertension 55 2010 946 952
11. D. Dong, Y. Duan, and J. Guo et al. Overexpression of calcineurin in mouse causes sudden cardiac death associated with decreased density of K + channels Cardiovasc Res 57 2003 320 332
12. J.D. Molkentin, J.R. Lu, and C.L. Antos et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy Cell 93 1998 215 228
13. E. Oie, R. Bjornerheim, O.P. Clausen, and H. Attramadal Cyclosporin A inhibits cardiac hypertrophy and enhances cardiac dysfunction during postinfarction failure in rats Am J Physiol Heart Circ Physiol 278 2000 H2115 H2123
14. M. Shimoyama, D. Hayashi, and E. Takimoto et al. Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy Circulation 100 1999 2449 2454
15. A.B. Aurora, A.I. Mahmoud, and X. Luo et al. MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca(2)(+) overload and cell death J Clin Invest 122 2012 1222 1232
16. T.E. Callis, and D.Z. Wang Taking microRNAs to heart Trends Mol Med 14 2008 254 260
17. P.A. Da Costa Martins, and L.J. De Windt MicroRNAs in control of cardiac hypertrophy Cardiovasc Res 93 2012 563 572
18. B. Cai, Z. Pan, and Y. Lu The roles of microRNAs in heart diseases: a novel important regulator Curr Med Chem 17 2010 407 411
19. M.M. Gladka, P.A. da Costa Martins, and L.J. De Windt Small changes can make a big difference - microRNA regulation of cardiac hypertrophy J Mol Cell Cardiol 52 2011 74 82
20. T.E. Callis, K. Pandya, and H.Y. Seok et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice J Clin Invest 119 2009 2772 2786
21. Y. Lu, Y. Zhang, and N. Wang et al. MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation Circulation 122 2010 2378 2387
22. C. Chen, R. Huo, and Y. Tong et al. Systemic heme oxygenase-1 transgenic overexpression aggravates pressure overload-induced cardiac hypertrophy in mice Cell Physiol Biochem 28 2011 25 32
23. J. Wang, Y. Song, and Y. Zhang et al. Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice Cell Res 22 2012 516 527
24. J. Ai, R. Zhang, and X. Gao et al. Overexpression of microRNA-1 impairs cardiac contractile function by damaging sarcomere assembly Cardiovasc Res 95 2012 385 393
25. W. Chu, C. Li, and X. Qu et al. Arsenic-induced interstitial myocardial fibrosis reveals a new insight into drug-induced long QT syndrome Cardiovasc Res 96 2012 90 98
26. H. Shan, Y. Zhang, and Y. Lu et al. Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines Cardiovasc Res 83 2009 465 472
27. Y. Zhang, L. Zhang, and W. Chu et al. Tanshinone IIA inhibits miR-1 expression through p38 MAPK signal pathway in post-infarction rat cardiomyocytes Cell Physiol Biochem 26 2010 991 998
28. X. Tan, J. Li, and X. Wang et al. Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway Int J Biol Sci 7 2011 383 389
29. B. Yang, H. Lin, and J. Xiao et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2 Nat Med 13 2007 486 491
30. R.S. Oliveira, J.C. Ferreira, and E.R. Gomes et al. Cardiac anti-remodelling effect of aerobic training is associated with a reduction in the calcineurin/NFAT signalling pathway in heart failure mice J Physiol 587 2009 3899 3910
31. P.A. da Costa Martins, K. Salic, and M.M. Gladka et al. MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling Nat Cell Biol 12 2010 1220 1227
32. Y. Yang, T. Ago, P. Zhai, M. Abdellatif, and J. Sadoshima Thioredoxin 1 negatively regulates angiotensin II-induced cardiac hypertrophy through upregulation of miR-98/let-7 Circ Res 108 2011 305 313
33. M. Asakawa, and I. Komuro Cardiac hypertrophy and calcium signaling Clin Calcium 11 2001 424 428
34. L. Li, W.E. Louch, and S.A. Niederer et al. Calcium dynamics in the ventricular myocytes of SERCA2 knockout mice: a modeling study Biophys J 100 2011 322 331
35. D.M. Bers Calcium cycling and signaling in cardiac myocytes Annu Rev Physiol 70 2008 23 49
36. 2 +-ATPase (SERCA2) gene promoter activity is decreased in response to severe left ventricular pressure-overload hypertrophy in rat hearts J Mol Cell Cardiol 31 1999 919 926
37. M.I. Miyamoto, F. del Monte, and U. Schmidt et al. Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure Proc Natl Acad Sci U S A 97 2000 793 798
38. J.D. Molkentin Calcineurin and beyond: cardiac hypertrophic signaling Circ Res 87 2000 731 738
39. R. Kumarswamy, A.R. Lyon, and I. Volkmann et al. SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway Eur Heart J 33 2012 1067 1075
40. A. Papolos, and W. Frishman SERCA2a, a potential gene therapy target in heart failure Cardiol Rev 46 2012 237 243
41. C.L. Jopling Regulation of hepatitis C virus by microRNA-122 Biochem Soc Trans 36 2008 1220 1223
42. S. Wang, H.M. Han, and Z.W. Pan et al. Choline inhibits angiotensin II-induced cardiac hypertrophy by intracellular calcium signal and p38 MAPK pathway Naunyn Schmiedebergs Arch Pharmacol 385 2012 823 831